Nuclea Biotechnologies, Inc., based in Pittsfield but with operations in Worcester, has announced that a kit using Carbonic Anhydrase IX has been classified by the Food and Drug Administration (FDA) as a Class I in vitro diagnostic (IVD) device for use on a Ventana Benchmark XT instrument.
Maintaining work-life balance is challenging for any parent, but for those who have children with autism, the problem is compounded.
Speakers featured at the second annual Central Massachusetts Autism Summit held at Assumption College Tuesday morning provided insight into the myriad obstacles parents face. Often, children with autism have other health conditions that add to their needs, from psychiatric diagnoses to allergies and gastrointestinal disorders, according to a presentation by Dr. Jean Frazier, director of the Eunice Kennedy Shriver Center at UMass Medical School in Worcester.
The College of the Holy Cross, whose comprehensive fundraising campaign “Become More” has crossed the halfway mark, has won a 2015 Council for Advancement and Support of Education (CASE) educational fundraising award.
A custom piece of Worcester craftsmanship has been installed at the United Nations in New York City just in time for the visit from Pope Francis, with a display created by Continental Wood Craft housing a Kuwaiti exhibit.
Frederick H. Eppinger announced Tuesday that he will step down as the president, CEO, and a director of the Hanover Insurance Group, headquartered in Worcester.
Standard and Poor's Rating Services has upgraded UMass Memorial Medical Center's outlook from negative to stable, citing improved financial performance and affirmed the Worcester hospital's BBB+ bond rating on Tuesday.